- Home
- / Dyno Therapeutics
Dyno Therapeutics
Total Funding
$109 M
Dyno Therapeutics Summary
Company Summary
- Overview
- Dyno Therapeutics is a biotechnology company that provides AI-powered gene therapies. It develops CapsidMap, a platform that uses AI to optimize adeno-associated virus (AAV) capsid vectors for the treatment of skeletal and cardiac muscle diseases.
- Type
- Private
- Status
- Active
- Founded
- 2018
- HQ
- Watertown, MA, US | view all locations
- Website
- https://www.dynotx.com
- Cybersecurity rating
Table of Contents
Key People
Alan Crane, Executive Chairman
Sam Sinai, Co-Founder & Head of Computation
Adrian Veres, CSO & Co-Founder
LocationsView all
1 location detected
Watertown, MA HQ
United States
343 Arsenal Street, Suite 101